Kings Path Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Kings Path Partners’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$576K	Hold
2025 Q1	$533K	Sell
2024 Q4	$885K	Hold
2024 Q3	$827K	Buy
2024 Q2	$580K	Buy